Frankfurt
30.12.25 | 08:17
12,800 Euro
-5,19 % -0,700
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 12,800 | 13,600 | 11:16 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| EXTENDICARE Aktie jetzt für 0€ handeln | |||||
| 16.12. | Extendicare Inc (2): Extendicare holder Sandpiper holdings decrease to 9.99% | 13 | Stockwatch | ||
| 15.12. | Sandpiper Group Reduces Its Position In Extendicare Inc. | 9 | CNW | ||
| 15.12. | Extendicare declares CAD 0.042 dividend | 3 | Seeking Alpha | ||
| 12.12. | Extendicare Inc.: Extendicare Announces December 2025 Dividend of C$0.042 per Share | 2 | GlobeNewswire (USA) | ||
| 04.12. | Extendicare, Bombardier, Calian at 52-Week Highs on News | 14 | Baystreet.ca | ||
| 04.12. | Extendicare stock rating upgraded by RBC Capital on CBI acquisition | 3 | Investing.com | ||
| 04.12. | Extendicare stock rating upgraded by BMO Capital on CBI acquisition | 13 | Investing.com | ||
| 04.12. | Extendicare Inc (2): Extendicare closes $200-million private placement | 2 | Stockwatch | ||
| 03.12. | Extendicare Inc.: Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares | 1 | GlobeNewswire (USA) | ||
| 24.11. | This analyst loves Extendicare | 2 | Cantech Letter | ||
| 20.11. | XFRA 5XE: WIEDERAUFNAHME/RESUMPTION | 163 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 20.11. | XFRA 5XE: AUSSETZUNG/SUSPENSION | 205 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEXTENDICARE INC.... ► Artikel lesen | |
| 19.11. | Extendicare Inc.: Extendicare to Expand its Home Health Care Business by Acquiring CBI Home Health for $570 Million in Cash Consideration | 279 | GlobeNewswire (Europe) | Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, ONTARIO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE)... ► Artikel lesen | |
| 17.11. | Barrick, CIBC, Extendicare at 52-Week Highs on News | 29 | Baystreet.ca | ||
| 12.11. | Earnings Call Transkript: Extendicare übertrifft im 3. Quartal 2025 die Erwartungen mit starkem Gewinn pro Aktie | 7 | Investing.com Deutsch | ||
| 12.11. | Extendicare reports Q3 results | 6 | Seeking Alpha | ||
| 12.11. | Extendicare Inc Profit Climbs In Q3 | 3 | RTTNews | ||
| 11.11. | Extendicare Inc. GAAP EPS of $0.28, revenue of $440.3M | 2 | Seeking Alpha | ||
| 11.11. | Extendicare Inc.: Extendicare Announces 2025 Third Quarter Results | 157 | GlobeNewswire (Europe) | MARKHAM, Ontario, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) today reported results for the three and nine months ended September 30, 2025. Third... ► Artikel lesen | |
| 07.11. | ATCO, Canadian Utilities, Extendicare at 52-Week Highs on News | 1 | Baystreet.ca |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,640 | -0,10 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,490 | -0,30 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,080 | -1,38 % | CARL ZEISS MEDITEC AG stürzt ab - Panik im TecDAX! | ||
| TELADOC HEALTH | 5,901 | +0,31 % | HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? | ||
| HIMS & HERS HEALTH | 29,170 | +0,69 % | TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside | ||
| BECTON DICKINSON | 165,55 | -0,18 % | BD faces hernia mesh lawsuit from Tela Bio | ||
| CARDINAL HEALTH | 175,55 | -0,37 % | Cardinal Health completes acquisition of Solaris Health | Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal... ► Artikel lesen | |
| RYMAN HEALTHCARE | 1,396 | -0,29 % | Ryman Healthcare Slid To Loss In H1 | WELLINGTON (dpa-AFX) - Ryman Healthcare Ltd. (RYM.NZ), a retirement village and rest home operator, on Thursday reported loss in the first half compared with the previous year. For the half... ► Artikel lesen | |
| ORGANON | 5,994 | -0,86 % | Dividendenbekanntmachungen (20.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLIENT INC US0193301092 0,03 USD 0,0259 EUR APPLIED MATERIALS INC US0382221051 0,46 USD 0,3986 EUR APPLIED MATERIALS INC CDR CA03822G1046 0... ► Artikel lesen | |
| CENTENE | 34,450 | -0,68 % | Centene Corporation Reports Third Quarter 2025 Results | -- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 --
Adjusted diluted EPS of $0.50 in the third quarter of 2025, including... ► Artikel lesen | |
| GENEDX | 129,34 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,620 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,940 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,840 | +0,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,860 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen |
Das Unternehmen EXTENDICARE INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -5,19 % bei einem Aktienkurs von 12,800 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXTENDICARE INC finden Sie auf Wallstreet Online.